Epidemiology of moderate-to-severe psoriasis: a comparison between psoriasis patients treated with biological agents, conventional systemic drugs and topical agents
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064211%3A_____%2F20%3AW0000006" target="_blank" >RIV/00064211:_____/20:W0000006 - isvavai.cz</a>
Alternative codes found
RIV/62156489:43110/22:43918460 RIV/00064173:_____/22:43920584 RIV/00216208:11110/22:10415432 RIV/00216208:11120/22:43920584 and 2 more
Result on the web
<a href="https://dx.doi.org/10.1080/09546634.2020.1826393" target="_blank" >https://dx.doi.org/10.1080/09546634.2020.1826393</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1080/09546634.2020.1826393" target="_blank" >10.1080/09546634.2020.1826393</a>
Alternative languages
Result language
angličtina
Original language name
Epidemiology of moderate-to-severe psoriasis: a comparison between psoriasis patients treated with biological agents, conventional systemic drugs and topical agents
Original language description
Introduction Understanding how different comorbidities and epidemiological factors are related to psoriasis severity can help us estimating patients' clinical outcome. Aim Establish possible prognostic factors of severe psoriasis. Methods Three groups of patients were included: 118 were on topical therapy, 83 used conventional systemic drugs, and 112 were treated with biological agents. Based on the fact that patients on topical therapy have a lower grade of disease severity than patients treated systemically, we compared a variety of comorbidities and epidemiological parameters between the three groups. Results Patients treated more aggressively have an increased risk of cardiovascular disease (p = .044), suffer more from depression (p = .020), hyperuricemia (p = .031) and nonspecific noninfectious liver disease (p = .005). Male gender (p < .001), increased height (p < .001), early age of disease onset (p < .001), viral upper respiratory infections (p = .049) and periods of hormonal changes (p = .045) are associated with these therapies. Conclusion Psoriasis severity is directly related to an increased risk of cardiovascular disease, depression, hyperuricemia and nonspecific noninfectious liver disease. Male gender, increased height, early age of disease onset, viral upper respiratory infections and periods of hormonal changes seem to be prognostic of higher degrees of psoriasis severity. We are pioneering the use of increased height and puberty, menopause/andropause as independent prognostic factors of psoriasis severity.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30216 - Dermatology and venereal diseases
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
JOURNAL OF DERMATOLOGICAL TREATMENT
ISSN
0954-6634
e-ISSN
1471-1753
Volume of the periodical
—
Issue of the periodical within the volume
20 Oct 2020
Country of publishing house
GB - UNITED KINGDOM
Number of pages
14
Pages from-to
-
UT code for WoS article
000579900300001
EID of the result in the Scopus database
2-s2.0-85093083096